Explore / Clinical trial
Clinical trial

Characterizing Clinical and Pharmacological Neuroimaging Biomarkers

Yale UniversityCompletedEarly Phase 1Started Apr 1, 2013143 enrolledUnited StatesNCT03842800

Abstract

This study is part of a larger overall study that seeks to characterize clinical and pharmacological neuroimaging biomarkers. The purpose of this registered protocol is understand the effect of emotion on cognitions by specifically examining the effect of reward processing on working memory in patients with schizophrenia.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

Cognitive Impairment

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.